Concepedia

Publication | Open Access

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

DOIFull Paper Access

19

Citations

35

References

2021

Year

Raajit K. Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, Benjamin H. Durham, Richard P. Koche, Barbara Spitzer, Shoron Mowla, Aishwarya Krishnan, Bing Li, Wenbin An,
Clinical Cancer Research

Abstract

The triple combination of ruxolitinib, LEE011, and PIM447 represents a promising therapeutic strategy with the potential to increase therapeutic responses in patients with MPN.

References

YearCitations

Page 1